It is positively correlated with APC mutation, which is an indicator of OS of CRC patients treated with ICIs.56 It appears that high infiltration of CD226+CD8+ T cells might be a survival marker associated with the outcome of ICI treatment in patients of different cancer types. The gene discussed is CD226; the disease is colorectal carcinoma.